Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
出版年份 2022 全文链接
标题
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
作者
关键词
-
出版物
Cancers
Volume 14, Issue 16, Pages 3991
出版商
MDPI AG
发表日期
2022-08-19
DOI
10.3390/cancers14163991
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer
- (2022) Loïc Reppel et al. Journal for ImmunoTherapy of Cancer
- Immune Checkpoint Blockade in Lung Carcinoids with Aggressive Behaviour: One More Arrow in Our Quiver?
- (2022) Sergio Di Molfetta et al. Journal of Clinical Medicine
- Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
- (2022) Edurne Arriola et al. Oncology and Therapy
- Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
- (2022) Robert I Haddad et al. Journal of the National Comprehensive Cancer Network
- CAR T cells in solid tumors: challenges and opportunities
- (2021) Faroogh Marofi et al. Stem Cell Research & Therapy
- Small-cell lung cancer
- (2021) Charles M. Rudin et al. Nature Reviews Disease Primers
- Immunotherapy in Neuroendocrine Neoplasms: Where Are We Now?
- (2021) Nicola Fazio et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
- (2021) A.-M.C. Dingemans et al. ANNALS OF ONCOLOGY
- "Present and future of immunotherapy in Neuroendocrine Tumors"
- (2021) Manuela Albertelli et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients
- (2021) Divya Bhagirath et al. Scientific Reports
- Survival and pretreatment prognostic factors for extensive‐stage small cell lung cancer: A comprehensive analysis of 358 patients
- (2021) Li‐Ling Huang et al. Thoracic Cancer
- Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
- (2021) Sergio Di Molfetta et al. Frontiers in Endocrinology
- Therapy considerations in neuroendocrine prostate cancer: what next?
- (2021) Himisha Beltran et al. ENDOCRINE-RELATED CANCER
- Molecular events in neuroendocrine prostate cancer development
- (2021) Yong Wang et al. Nature Reviews Urology
- Update on Targeted Therapy in Medullary Thyroid Cancer
- (2021) Christian Okafor et al. Frontiers in Endocrinology
- A highly-specific fully-human antibody and CAR-T cells targeting CD66e/CEACAM5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivo
- (2021) Du-San Baek et al. CANCER LETTERS
- Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer
- (2021) Sanaz Taromi et al. CANCER LETTERS
- Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
- (2021) Apar Kishor P. Ganti et al. Journal of the National Comprehensive Cancer Network
- CAR-T Cell Therapy in Cancer: Tribulations and Road Ahead
- (2020) Qingyang Zhang et al. Journal of Immunology Research
- Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study
- (2020) Charles M. Rudin et al. JOURNAL OF CLINICAL ONCOLOGY
- HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery
- (2020) Steven C Katz et al. Journal for ImmunoTherapy of Cancer
- Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks
- (2020) Giuseppe Fanciulli et al. Journal of Clinical Medicine
- Eradication of neuroblastoma by T cells redirected with an optimized GD2-specific chimeric antigen receptor and interleukin-15
- (2019) Yuhui Chen et al. CLINICAL CANCER RESEARCH
- Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions
- (2019) Marco Gallo et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges
- (2019) Alessandro Leonetti et al. CELLULAR ONCOLOGY
- HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases
- (2019) Steven C. Katz et al. CANCER GENE THERAPY
- Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma
- (2019) John K. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- DLL3: an emerging target in small cell lung cancer
- (2019) Dwight H. Owen et al. Journal of Hematology & Oncology
- Non-conventional doses of somatostatin analogs in patients with progressing well differentiated neuroendocrine tumor
- (2019) Giuseppe Lamberti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Neuroendocrine Cancer of the Prostate
- (2019) Noémi Kránitz et al. PATHOLOGY & ONCOLOGY RESEARCH
- Clinical features of neuroendocrine prostate cancer
- (2019) Vincenza Conteduca et al. EUROPEAN JOURNAL OF CANCER
- Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
- (2019) Luis Paz-Ares et al. LANCET
- Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms
- (2018) Federica Grillo et al. ENDOCRINE-RELATED CANCER
- Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models
- (2018) Denise L. Crossland et al. ONCOGENE
- Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer
- (2018) John K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Medullary Thyroid Cancer
- (2018) David Viola et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- The safety of available treatments options for neuroendocrine tumors
- (2017) A. Faggiano et al. Expert Opinion On Drug Safety
- Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years
- (2017) Reese W. Randle et al. SURGERY
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives
- (2017) J. Gauthier et al. Current Research in Translational Medicine
- Medullary Carcinoma
- (2017) R. Michael Tuttle et al. Journal of the National Comprehensive Cancer Network
- Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors
- (2016) Manisha H. Shah et al. INVESTIGATIONAL NEW DRUGS
- Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial
- (2016) C. Bodet-Milin et al. JOURNAL OF NUCLEAR MEDICINE
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
- (2016) M. Pavel et al. NEUROENDOCRINOLOGY
- Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases
- (2015) S. C. Katz et al. CLINICAL CANCER RESEARCH
- Expression of cadherin 17 in well-differentiated neuroendocrine tumours
- (2015) Anthony N Snow et al. HISTOPATHOLOGY
- Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
- (2015) Samuel A. Wells et al. THYROID
- Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
- (2014) Jonathan I. Epstein et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist
- (2014) S. Sarvi et al. CANCER RESEARCH
- Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies
- (2013) Federica Barbieri et al. DRUG DISCOVERY TODAY
- Current Understanding and Management of Medullary Thyroid Cancer
- (2013) M. Roy et al. ONCOLOGIST
- The Basic Principles of Chimeric Antigen Receptor Design
- (2013) Michel Sadelain et al. Cancer Discovery
- Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system
- (2008) Min-Cheng Su et al. MODERN PATHOLOGY
- Current Management of Medullary Thyroid Cancer
- (2008) R. S. Sippel et al. ONCOLOGIST
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started